CSIMarket
 


Opiant Pharmaceuticals Inc   (OPNT)
Other Ticker:  
 
 

OPNT's EPS Net Growth by Quarter and Year

Opiant Pharmaceuticals Inc 's EPS Net results by quarter and year




OPNT EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.10 -0.16 0.15
III Quarter September -1.93 0.56 0.15 1.97
II Quarter June -2.31 0.31 -0.05 0.31
I Quarter March -2.43 -0.66 -0.40 -0.44
FY   -6.67 0.31 -0.46 1.99



OPNT EPS Net third quarter 2022 Y/Y Growth Comment
Opiant Pharmaceuticals Inc in the third quarter 2022 recorded EPS net loss of $ -1.93 .

According to the results reported in the third quarter 2022, Opiant Pharmaceuticals Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Opiant Pharmaceuticals Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2022.




OPNT EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - 273.33 % -92.39 % -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Opiant Pharmaceuticals Inc 's third quarter 2022 EPS Net $ -1.93 OPNT's Income Statement
Opiant Pharmaceuticals Inc 's third quarter 2021 EPS Net $ 0.56 Quarterly OPNT's Income Statement
New: More OPNT's historic EPS Net Growth >>


OPNT EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -82.14 % - -92.39 %
III Quarter September - 80.65 % - 535.48 %
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Opiant Pharmaceuticals Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OPNT's III. Quarter Q/Q EPS Net Comment
Although Opiant Pharmaceuticals Inc in the III. Quarter 2022 admitted EPS net loss of $ -1.93 , some analyst point out, that those numbers are improvement compare to the -2.31 in the second quarter.

Within Major Pharmaceutical Preparations industry Opiant Pharmaceuticals Inc achieved highest sequential EPS Net growth. While Opiant Pharmaceuticals Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OPNT's III. Quarter Q/Q EPS Net Comment
Despite the fact, that Opiant Pharmaceuticals Inc in the III. Quarter 2022 admitted EPS net loss of $ -1.93 , it should be point out, that those numbers point to improvement relative to the -2.31 in the second quarter.

Within Major Pharmaceutical Preparations industry Opiant Pharmaceuticals Inc achieved highest sequential EPS Net growth. While Opiant Pharmaceuticals Inc 's EPS Net growth quarter on quarter, overall rank is .


Opiant Pharmaceuticals Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative EPS Net 12 Months Ending $ -6.57 $ -4.08 $ -1.46 $ 0.31 $ 0.05
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - 522.65 % -
Seq. EPS Net Growth (TTM) Overall Ranking # 60 # 0 # 0 # 35 # 0




Cumulative EPS Net growth Comment
Opiant Pharmaceuticals Inc realized trailing twelve months EPS net loss of $ -7 , in the Sep 30 2022, compare to EPS Net of $ 0 a year ago.

Opiant Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 60
Cumulative EPS Net growth Comment
Opiant Pharmaceuticals Inc realized trailing twelve months EPS net loss of $ -7 , in the Sep 30 2022, compare to EPS Net of $ 0 a year ago.

Opiant Pharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 2
S&P 500 # 60




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
OPNT's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for OPNT's Competitors
EPS Net Growth for Opiant Pharmaceuticals Inc 's Suppliers
EPS Net Growth for OPNT's Customers

You may also want to know
OPNT's Annual Growth Rates OPNT's Profitability Ratios OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Roe OPNT's Valuation Ratios OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio
OPNT's Roa OPNT's Inventory Turnover Ratio OPNT's Growth Rates OPNT's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2022
Addus Homecare Corporation-1.39%$ -1.389 
Zoetis Inc -2.59%$ -2.586 
Universal Health Services Inc -3.85%$ -3.846 
Henry Schein Inc-5.22%$ -5.217 
Charles River Laboratories International inc -6.47%$ -6.468 
Synaptogenix Inc -8.51%$ -8.511 
Semler Scientific Inc -9.80%$ -9.804 
Sotera Health Company-10.00%$ -10.000 
National Research Corporation-13.16%$ -13.158 
Intuitive Surgical Inc -13.46%$ -13.462 
Retractable Technologies inc -15.79%$ -15.789 
Meridian Bioscience Inc -16.32%$ -16.320 
Lemaitre Vascular Inc -16.67%$ -16.667 
Ironwood Pharmaceuticals inc -17.65%$ -17.647 
Molecular Templates inc -18.52%$ -18.519 
Regeneron Pharmaceuticals Inc -18.63%$ -18.632 
Progyny Inc -23.53%$ -23.529 
Zynex inc -23.53%$ -23.529 
Maravai Lifesciences Holdings Inc -24.44%$ -24.444 
Docgo Inc -25.00%$ -25.000 
Viemed Healthcare Inc -25.00%$ -25.000 
Merck and Co Inc -28.89%$ -28.889 
Organon and Co -29.92%$ -29.921 
Gilead Sciences Inc -30.73%$ -30.732 
Abbott Laboratories-30.77%$ -30.769 
West Pharmaceutical Services Inc -31.17%$ -31.169 
Alpha Pro Tech Ltd -33.33%$ -33.333 
Laboratory Corporation Of America Holdings-35.54%$ -35.537 
Lhc Group Inc -36.36%$ -36.364 
Phibro Animal Health Corporation-37.50%$ -37.500 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com